Thought I might mention a bit about broker reports - the downgrade to a HOLD from BUY (with price target unchanged at ~$37) was cited as the reason for CUV shares falling more than 20%. That is a fallacy,
ROTFL. Mitsubishi Tanabe are likely have a competing product MT-7117 on the market within three years. They are already in Phase 3 trials for EPP and Phase 2 for Systemic Sclerosis.
https://www.mt-pharma.co.jp/e/develop/pipeline.html
HC the Number One source for crackpot conspiracy theories.
- Forums
- ASX - By Stock
- CLINUVEL AVOIDS 2ND STRIKE, AUSSIE BIOTECH GOES FROM STRENGTH TO STRENGTH (possible AFR headline tomorrrow)
Thought I might mention a bit about broker reports - the...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.99 |
Change
-0.170(1.12%) |
Mkt cap ! $748.6M |
Open | High | Low | Value | Volume |
$15.20 | $15.20 | $14.81 | $606.5K | 40.47K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 170 | $14.97 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.99 | 63 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 170 | 14.950 |
2 | 41 | 14.940 |
3 | 169 | 14.930 |
5 | 418 | 14.920 |
1 | 33 | 14.910 |
Price($) | Vol. | No. |
---|---|---|
14.970 | 36 | 1 |
14.990 | 34 | 1 |
15.000 | 34 | 1 |
15.010 | 133 | 2 |
15.020 | 141 | 3 |
Last trade - 13.51pm 18/09/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |